BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Pharm Country

  Alexion Pharmaceuticals Inc. to Join the NASDAQ-100 Index Beginning April 4, 2011

  March 30, 2011

   · 

  1 min read
• Bio NC

  Merz Pharmaceuticals, LLC Announces New Centers for Medicare & Medicaid Services Billing Q-Code for Xeomin(R) (incobotulinumtoxinA)

  March 30, 2011

   · 

  8 min read
• Deals

  Neuro-Biotech Corp. Announces Resumption Of The Buyout Offer At $0.15 From AURIC Pharma Science

  March 30, 2011

   · 

  1 min read
• Business

  Nephros Inc. Reports 2010 Fourth Quarter and Full Year Financial Results

  March 30, 2011

   · 

  13 min read
• Business

  NewCardio Announces Financial Results for Its 2010 Fourth Quarter and Full Year

  March 30, 2011

   · 

  10 min read
• Biotech Bay

  Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference

  March 30, 2011

   · 

  1 min read
• Policy

  Vexim, Specialist in Minimally Invasive Anatomical Restoration of Vertebral Compression Fractures, is Awarded FDA Certification for its COHESION(R) Cement

  March 30, 2011

   · 

  3 min read
• Business

  Microvisk Technologies Announces New Board Appointments ahead of Product Launch

  March 30, 2011

   · 

  8 min read
• Deals

  Comprehensive Clinical Development Finalizes Acquisition of Charles River Clinical Services

  March 30, 2011

   · 

  1 min read
• Business

  Regulus Therapeutics, Inc. Receives Exclusive License for Intellectual Property to microRNA-33a and microRNA-33b to Treat Diseases that Include Atherosclerosis and Metabolic Syndrome

  March 30, 2011

   · 

  1 min read